{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-047071","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2024-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.947783+00:00","generated_at":"2026-05-29T23:37:50.851888+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"AngioDynamics shareholders approve all proposals at 2024 annual meeting including equity plan amendment","bullets":["Elected three Class III directors: Burgess, Johnson, Licitra each with >24.8M votes for, 5.99M broker non-votes.","Ratified Deloitte & Touche as FY2025 auditor with 34.1M for, 155k against, 16.5k abstain.","Advisory approval of exec compensation: 26.0M for, 1.25M against, 1.04M abstain, 5.99M broker non-votes.","Approved amended 2020 Equity Incentive Plan increasing share reserve: 23.2M for, 5.06M against, 35k abstain, 5.99M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-047071","json":"https://secwatch.observer/filing/0001140361-24-047071.json","markdown":"https://secwatch.observer/filing/0001140361-24-047071.md","text":"https://secwatch.observer/filing/0001140361-24-047071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124047071/0001140361-24-047071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124047071/ef20038737_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:37:50.851888+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}